RalB GTPase-Mediated Activation of the IκB Family Kinase TBK1 Couples Innate Immune Signaling to Tumor Cell Survival

Cell

Volumn 127, Issue 1, 2006, Pages 157-170

  Chien, Yuchen ^a   Kim, Sungchan ^a   Bumeister, Ron ^a   Loo, Yueh Ming ^a   Kwon, Sung Won ^a   Johnson, Cynthia L ^a   Balakireva, Mirey G ^b   Romeo, Yves ^b   Kopelovich, Levy ^c   Gale Jr , Michael ^a   Yeaman, Charles ^d   Camonis, Jacques H ^b   Zhao, Yingming ^a   White, Michael A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b INSTITUT CURIE   (France)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; I KAPPA B KINASE; RAL PROTEIN; RALB PROTEIN; TBK1 PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; CELL SURVIVAL; CELL TRANSFORMATION; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR CELL;

EID: 33749165933     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2006.08.034     Document Type: Article

References (51)

1. Abrams J.M., and White M.A. Coordination of cell death and the cell cycle: linking proliferation to death through private and communal couplers. Curr. Opin. Cell Biol. 16 (2004) 634-638
2. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413 (2001) 732-738
3. Balachandran S., Thomas E., and Barber G.N. A FADD-dependent innate immune mechanism in mammalian cells. Nature 432 (2004) 401-405
4. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430 (2004) 257-263
5. Bonnard M., Mirtsos C., Suzuki S., Graham K., Huang J., Ng M., Itie A., Wakeham A., Shahinian A., Henzel W.J., et al. Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J. 19 (2000) 4976-4985
6. Buss H., Dorrie A., Schmitz M.L., Hoffmann E., Resch K., and Kracht M. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J. Biol. Chem. 279 (2004) 55633-55643
7. Camonis J.H., and White M.A. RalGTPases: corrupting the exocyst in cancer cells. Trends Cell Biol. 15 (2005) 327-332
8. Cantor S.B., Urano T., and Feig L.A. Identification and characterization of Ral-binding protein 1, a potential downstream target of RalGTPases. Mol. Cell. Biol. 15 (1995) 4578-4584
9. Chien Y., and White M.A. RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival. EMBO Rep. 4 (2003) 800-806
10. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11 (1983) 1475-1489
11. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3 (2003) 11-22
12. Evan G.I., and Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 411 (2001) 342-348
13. Feig L.A. RalGTPases: approaching their 15 minutes of fame. Trends Cell Biol. 13 (2003) 419-425
14. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.M., and Maniatis T. IKKepsilon and TBK1 are essential components of the IRF-3 signaling pathway. Nat. Immunol. 4 (2003) 491-496
15. Formstecher E., Aresta S., Collura V., Hamburger A., Meil A., Trehin A., Reverdy C., Betin V., Maire S., Brun C., et al. Protein interaction mapping: a Drosophila case study. Genome Res. 15 (2005) 376-384
16. Foy E., Li K., Wang C., Sumpter Jr. R., Ikeda M., Lemon S.M., and Gale Jr. M. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300 (2003) 1145-1148
17. Fujita F., Taniguchi Y., Kato T., Narita Y., Furuya A., Ogawa T., Sakurai H., Joh T., Itoh M., Delhase M., et al. Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling. Mol. Cell. Biol. 23 (2003) 7780-7793
18. Fukai S., Matern H.T., Jagath J.R., Scheller R.H., and Brunger A.T. Structural basis of the interaction between RalA and Sec5, a subunit of the sec6/8 complex. EMBO J. 22 (2003) 3267-3278
19. Gonzalez-Garcia A., Pritchard C.A., Paterson H.F., Mavria G., Stamp G., and Marshall C.J. RalGDS is required for tumor formation in a model of skin carcinogenesis. Cancer Cell 7 (2005) 219-226
20. Green D.R., and Evan G.I. A matter of life and death. Cancer Cell 1 (2002) 19-30
21. Grindstaff K.K., Yeaman C., Anandasabapathy N., Hsu S.C., Rodriguez-Boulan E., Scheller R.H., and Nelson W.J. Sec6/8 complex is recruited to cell-cell contacts and specifies transport vesicle delivery to the basal-lateral membrane in epithelial cells. Cell 93 (1998) 731-740
22. Gromley A., Yeaman C., Rosa J., Redick S., Chen C.T., Mirabelle S., Guha M., Sillibourne J., and Doxsey S.J. Centriolin anchoring of exocyst and SNARE complexes at the midbody is required for secretory-vesicle-mediated abscission. Cell 123 (2005) 75-87
23. Guo W., Sacher M., Barrowman J., Ferro-Novick S., and Novick P. Protein complexes in transport vesicle targeting. Trends Cell Biol. 10 (2000) 251-255
24. Hamad N.M., Elconin J.H., Karnoub A.E., Bai W., Rich J.N., Abraham R.T., Der C.J., and Counter C.M. Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev. 16 (2002) 2045-2057
25. Hiscott J. Another detour on the Toll road to the interferon antiviral response. Nat. Struct. Mol. Biol. 11 (2004) 1028-1030
26. Hoffmann J.A., and Reichhart J.M. Drosophila innate immunity: an evolutionary perspective. Nat. Immunol. 3 (2002) 121-126
27. Jullien-Flores V., Dorseuil O., Romero F., Letourneur F., Saragosti S., Berger R., Tavitian A., Gacon G., and Camonis J.H. Bridging RalGTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity. J. Biol. Chem. 270 (1995) 22473-22477
28. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441 (2006) 101-105
29. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., Ishii K.J., Takeuchi O., and Akira S. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6 (2005) 981-988
30. Lee H.K., Dunzendorfer S., Soldau K., and Tobias P.S. Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity 24 (2006) 153-163
31. Leulier F., Parquet C., Pili-Floury S., Ryu J.H., Caroff M., Lee W.J., Mengin-Lecreulx D., and Lemaitre B. The Drosophila immune system detects bacteria through specific peptidoglycan recognition. Nat. Immunol. 4 (2003) 478-484
32. Lowe S.W., Cepero E., and Evan G. Intrinsic tumour suppression. Nature 432 (2004) 307-315
33. Lubyova B., Kellum M.J., Frisancho A.J., and Pitha P.M. Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7. J. Biol. Chem. 279 (2004) 7643-7654
34. McWhirter S.M., Fitzgerald K.A., Rosains J., Rowe D.C., Golenbock D.T., and Maniatis T. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc. Natl. Acad. Sci. USA 101 (2004) 233-238
35. McWhirter S.M., Tenoever B.R., and Maniatis T. Connecting mitochondria and innate immunity. Cell 122 (2005) 645-647
36. Mitin N., Rossman K.L., and Der C.J. Signaling interplay in Ras superfamily function. Curr. Biol. 15 (2005) R563-R574
37. Moskalenko S., Henry D.O., Rosse C., Mirey G., Camonis J.H., and White M.A. The exocyst is a Ral effector complex. Nat. Cell Biol. 4 (2002) 66-72
38. Moskalenko S., Tong C., Rosse C., Mirey G., Formstecher E., Daviet L., Camonis J., and White M.A. RalGTPases regulate exocyst assembly through dual subunit interactions. J. Biol. Chem. 278 (2003) 51743-51748
39. Murthy M., Garza D., Scheller R.H., and Schwarz T.L. Mutations in the exocyst component Sec5 disrupt neuronal membrane traffic, but neurotransmitter release persists. Neuron 37 (2003) 433-447
40. Novick P., and Guo W. Ras family therapy: Rab, Rho and Ral talk to the exocyst. Trends Cell Biol. 12 (2002) 247-249
41. Park S.H., and Weinberg R.A. A putative effector of Ral has homology to Rho/Rac GTPase activating proteins. Oncogene 11 (1995) 2349-2355
42. Rangarajan A., Hong S.J., Gifford A., and Weinberg R.A. Species- and cell type-specific requirements for cellular transformation. Cancer Cell 6 (2004) 171-183
43. Repasky G.A., Chenette E.J., and Der C.J. Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?. Trends Cell Biol. 14 (2004) 639-647
44. Sato S., Sugiyama M., Yamamoto M., Watanabe Y., Kawai T., Takeda K., and Akira S. TRIF associates with TRAF6 and TBK1, and activates two distinct transcription factors, NF-kappa B and IRF-3, in the Toll-like receptor signaling. J. Immunol. 171 (2003) 4304-4310
45. Sharma S., tenOever B.R., Grandvaux N., Zhou G.P., Lin R., and Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 300 (2003) 1148-1151
46. Shipitsin M., and Feig L.A. RalA but not RalB enhances polarized delivery of membrane proteins to the basolateral surface of epithelial cells. Mol. Cell. Biol. 24 (2004) 5746-5756
47. Sugihara K., Asano S., Tanaka K., Iwamatsu A., Okawa K., and Ohta Y. The exocyst complex binds the small GTPase RalA to mediate filopodia formation. Nat. Cell Biol. 4 (2002) 73-78
48. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K., and Akira S. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301 (2003) 640-643
49. Zhang L., Zhang J., Lambert Q., Der C.J., Del Valle L., Miklossy J., Khalili K., Zhou Y., and Pagano J.S. Interferon regulatory factor 7 is associated with Epstein-Barr virus-transformed central nervous system lymphoma and has oncogenic properties. J. Virol. 78 (2004) 12987-12995
50. Zhao Y., Kwon S.W., Anselmo A., Kaur K., and White M.A. Broad spectrum identification of cellular small ubiquitin-related modifier (SUMO) substrate proteins. J. Biol. Chem. 279 (2004) 20999-21002
51. Zhao Y., Zhang W., and Kho Y. Proteomic analysis of integral plasma membrane proteins. Anal. Chem. 76 (2004) 1817-1823